KNSA Competitors & Alternatives

Compare Kiniksa Pharmaceuticals Ltd with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

KNSA

Main Stock
$60.31
Tradestie Score
59
Market Cap
$2.86B
P/E Ratio
62.8
Revenue Growth
0.6%
Analyst Upside
+5.3%

Top Competitors

47 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
KRYS Krystal Biotech, Inc. Common Stock
$351.48
$5.20B 46.2 60 Compare
ALKS Alkermes Inc. plc
$51.35
$5.06B 51.1 65 Compare
CRNX Crinetics Pharmaceuticals, Inc.
$36.22
$3.92B - 61 Compare
MIRM Mirum Pharmaceuticals, Inc. Common Stock
$112.69
$3.67B - 58 Compare
LNTH Lantheus Holdings, Inc
$104.95
$3.51B 25.4 64 Compare
AMRX Amneal Pharmaceuticals, Inc. Class A Common Stock
$17.28
$3.26B 43.5 60 Compare
PBH Prestige Consumer Healthcare Inc.
$46.86
$3.12B 11.6 59 Compare
PRGO PERRIGO COMPANY PLC
$9.65
$3.10B - 56 Compare
INDV Indivior PLC Ordinary Shares
$40.68
$2.93B 19.7 64 Compare
HCM HUTCHMED (China) Limited American Depositary Shares
$10.26
$2.74B 3.8 55 Compare

Data updated: Jun 24, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

47 stocks in this industry